SAN DIEGO, Dec. 19, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (“Apricus” or the “Company”) (Nasdaq:APRI) (www.apricusbio.com), today announced that France’s National Agency for Medicines and Health Products Safety (ANSM) has granted national phase approval to Vitaros®, indicated for the treatment of patients with erectile dysfunction (“ED”). The Company has now received a total of seven national phase approvals for Vitaros®, including France, Germany, Ireland, Italy, the Netherlands, Sweden and the United Kingdom (the “UK”) following its broad approval by European health authorities in June 2013.
Help employers find you! Check out all the jobs and post your resume.
